Australian Medical Association
As of April 1, a number of changes have been made to the Pharmaceutical Benefits Scheme (PBS) listings for adalimumab.
This includes the listing of multiple biosimilar brands in various formulations, strengths and pack sizes.
More information will soon be available on the PBS website however to assist in increasing the preparedness for this change, we suggest reading here.
/AMA/AusMed News. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
